Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.

Lafrance JP, Miller DR.

Am J Kidney Dis. 2012 Jul;60(1):82-9. doi: 10.1053/j.ajkd.2012.02.328. Epub 2012 Apr 12.

PMID:
22503390
2.

Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.

Lafrance JP, Miller DR.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):923-31. doi: 10.1002/pds.1798.

PMID:
19585463
4.

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

Arthritis Rheum. 2006 May;54(5):1378-89.

5.

Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.

Castellsague J, Holick CN, Hoffman CC, Gimeno V, Stang MR, Perez-Gutthann S.

Pharmacotherapy. 2009 Dec;29(12):1397-407. doi: 10.1592/phco.29.12.1397.

PMID:
19947799
7.

Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.

Patterson MK, Castellsague J, Walker AM.

Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):982-8. doi: 10.1002/pds.1639.

PMID:
18711705
8.

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.

Arthritis Res Ther. 2005;7(2):R333-42. Epub 2005 Jan 17.

9.

Factors associated with celecoxib and rofecoxib utilization.

Rawson NS, Nourjah P, Grosser SC, Graham DJ.

Ann Pharmacother. 2005 Apr;39(4):597-602. Epub 2005 Mar 8.

PMID:
15755796
10.

Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.

Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C.

Circulation. 2006 Jun 27;113(25):2906-13. Epub 2006 Jun 19.

11.

Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan.

Chang CH, Chen HC, Lin JW, Kuo CW, Shau WY, Lai MS.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):763-71. doi: 10.1002/pds.2140. Epub 2011 May 25.

PMID:
21618340
12.
13.

Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.

Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM.

Am J Epidemiol. 2006 Nov 1;164(9):881-9. Epub 2006 Sep 27.

PMID:
17005625
14.

Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.

Haag MD, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH.

Arch Intern Med. 2008 Jun 9;168(11):1219-24. doi: 10.1001/archinte.168.11.1219.

PMID:
18541831
15.

Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.

McGettigan P, Han P, Jones L, Whitaker D, Henry D.

Br J Clin Pharmacol. 2008 Jun;65(6):927-34. doi: 10.1111/j.1365-2125.2008.03121.x. Epub 2008 Apr 1.

17.

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.

Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT.

BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.

PMID:
21727167
18.

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.

Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J.

Circulation. 2004 May 4;109(17):2068-73. Epub 2004 Apr 19.

19.

Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.

Winkelmayer WC, Waikar SS, Mogun H, Solomon DH.

Am J Med. 2008 Dec;121(12):1092-8. doi: 10.1016/j.amjmed.2008.06.035.

PMID:
19028206
20.

Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.

Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.

Am J Manag Care. 2002 Oct;8(15 Suppl):S401-13.

Supplemental Content

Support Center